A decrease in vitamin D levels is associated with methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia

N. Oosterom*, N. F. Dirks, S. G. Heil, R. de Jonge, W. J. E. Tissing, R. Pieters, M. M. van den Heuvel-Eibrink, A. C. Heijboer, S. M. F. Pluijm

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
168 Downloads (Pure)

Abstract

Purpose: Children with acute lymphoblastic leukemia (ALL) are at increased risk of vitamin D deficiency, which might make them more susceptible to developing adverse events. Previous studies showed that low vitamin D levels were associated with an increased inflammatory mucosal state and impaired mucosal tissue barriers. We examined the prevalence of vitamin D deficiency and studied the association between vitamin D levels and methotrexate (MTX)-induced oral mucositis in pediatric ALL.

Methods: We assessed 25-hydroxyvitamin D (25(OH)D3) and 24,25-dihydroxyvitamin D (24,25(OH)2D3) levels in 99 children with ALL before the start of 4 × 5 g/m2 high-dose methotrexate (HD-MTX) (T0) and in 81/99 children after discontinuation of HD-MTX (T1). Two cutoff values for vitamin D deficiency exist: 25(OH)D3 levels < 30 and < 50 nmol/L. Oral mucositis was defined as grade ≥ 3 according to the National Cancer Institute Criteria.

Results: Vitamin D deficiency occurred in respectively 8% (< 30 nmol/L) and 33% (< 50 nmol/L) of the patients at T0, and more frequently in children > 4 years of age as compared to children between 1 and 4 years of age. A decrease in 25(OH)D3 levels during HD-MTX therapy was associated with developing severe oral mucositis (OR 1.6; 95% CI [1.1–2.4]). 25(OH)D3 and 24,25(OH)2D3 levels at T0 and the change in 24,25(OH)2D3 levels during therapy were not associated with the development of severe oral mucositis.

Conclusions: This study showed that vitamin D deficiency occurs frequently in pediatric ALL patients above the age of 4years. A decrease in 25(OH)D-3 levels during MTX therapy was observed in children with ALL that developed severe oral mucositis.

Original languageEnglish
Pages (from-to)183-190
Number of pages8
JournalSupportive Care in Cancer
Volume27
Issue number1
DOIs
Publication statusPublished - Jan-2019

Keywords

  • Vitamin D
  • Acute lymphoblastic leukemia
  • Oral mucositis
  • Methotrexate
  • D DEFICIENCY
  • CONFOUNDER-SELECTION
  • DISEASE
  • HEALTH
  • CANCER
  • DETERMINANTS
  • CHEMOTHERAPY
  • MANAGEMENT

Cite this